2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
First Business Financial Services furnished an investor presentation on its second-quarter 2026 results and strategy. Diluted EPS was $1.84 and net income available to common was $15.4 million, up 28% from the linked quarter and 37% from a year earlier, though Q2 EPS included a $0.14 net one-time benefit. The company also exited out-of-footprint SBA 7(a) lending in May 2026 and estimates a $0.03 quarterly EPS benefit in 2027.
Q2 2026 diluted EPS $1.84 (up 28% linked quarter, up 36% year over year); net income available to common $15.4 million
Q2 EPS included a $0.14 net benefit from a $1.5 million deferred tax asset valuation allowance reversal, partly offset by $405,000 in severance costs
Operating revenue $46.7 million, up 14% year over year for the first half comparison in the table is $91.0 million, up 11%
Out-of-footprint SBA 7(a) lending exit completed in May 2026; estimated 2027 quarterly EPS benefit of $0.03
On August 19, 2026, Amylyx entered an underwriting agreement to sell 14,090,000 new shares of common stock at $35.50 per share, with a 30-day option for underwriters to buy up to 2,113,500 more. Expected net proceeds are about $471.7 million, or about $542.5 million if the option is exercised in full, and the company plans to use them to fund a potential U.S. launch of avexitide if approved, add manufacturing capacity, and for research, working capital and general corporate purposes. The offering is expected to close on August 21, 2026, and the new shares add to the company's outstanding share count.
14,090,000 firm shares offered at $35.50 per share, all sold by the company
Underwriters have a 30-day option to buy up to 2,113,500 additional shares
Expected net proceeds of about $471.7 million, or about $542.5 million if the option is fully exercised
Offering expected to close on August 21, 2026, subject to customary closing conditions
On August 20, 2026, Charter Communications completed its transactions with Cox Communications and its acquisition of Liberty Broadband. Cox Enterprises now owns about 26% of Charter's fully diluted shares, and about $12 billion of Cox debt and finance leases remains outstanding at Charter subsidiaries. Charter's board also changed, with Alex Taylor becoming Chairman and Liberty Broadband no longer a direct shareholder.
Charter paid $3.5 billion in cash to Cox NewCo for the Cox equity sale, and Charter Holdings paid $724 million in cash plus $6.0 billion of convertible preferred units.
Charter issued the equivalent of just over 46 million Charter shares to a subsidiary of Cox Enterprises, and Cox Enterprises now owns about 26% of fully diluted shares.
Liberty Broadband common holders received 0.236 of a Charter Class A share per share, a net decrease of about 4.7 million Charter shares outstanding.
Alex Taylor was appointed Chairman, Eric Zinterhofer became lead independent director, and Chris Winfrey continues as President and CEO.
Coty Inc. said Soraya Benchikh, formerly Chief Financial Officer of British American Tobacco, will succeed Laurent Mercier as Chief Financial Officer effective September 1, 2026, with Mercier serving through August 31, 2026. The company said Mercier's departure is not the result of any disagreement on operations, policies or practices, and the filing also raises Interim Chief Executive Officer Markus Strobel's base salary to $1.6 million from $1.25 million.
Mercier remains CFO through August 31, 2026; Benchikh takes over September 1, 2026.
Benchikh's employment agreement sets annual gross fixed compensation of €1,165,000 and a $2.5 million sign-on RSU award.
Strobel's base salary rises to $1.6 million from $1.25 million, effective September 1, 2026, with target bonus raised to 170% from 150%.
Benchikh will join Coty's Executive Committee and report directly to Strobel, per the press release.
On August 14, 2026, Aptera Motors entered a Strategic Partnership Agreement with Shanghai Launch Automotive Technology under which Launch will provide manufacturing and contract-engineering work. Aptera agreed to pay up to RMB 300 million, with two-thirds of each approved invoice paid in cash up to RMB 200 million and one-third paid through warrants up to RMB 100 million. The filing says the deal could result in additional share issuance to Launch, which may dilute existing shareholders.
Agreement effective August 14, 2026; Launch to perform manufacturing, engineering, tooling and testing under agreed work orders
Initial warrants for 3,369,629 Class B shares, valued at RMB 50 million, issued to Launch on the effective date; not exercisable until credited against approved invoices
Warrants have a five-year term, with exercise prices of $2.20 for initial warrants and at least $2.25 per share for later warrants
Warrants are subject to a 4.99% beneficial ownership limit and a 19.99% exchange cap unless Nasdaq stockholder approval is obtained
Cosmos Health reported second-quarter 2026 revenue of $18.99 million, up 28.8% from a year earlier, and said it was the highest second-quarter revenue in its history. The net loss widened to $6.09 million from $2.83 million, which the company attributed mainly to $2.65 million of non-cash charges, chiefly fair value adjustments on its financing arrangements.
Q2 2026 revenue was $18.99 million, up 28.8% from $14.75 million; first-half revenue was $36.91 million, up 29.7%.
Q2 2026 net loss was $6.09 million, compared with $2.83 million in Q2 2025; first-half net loss was $8.89 million versus $3.65 million.
Q2 2026 gross profit was $1.51 million, up 29.9%; excluding $0.33 million of sales discount reversals, adjusted gross profit was $1.84 million, up 58.4%.
The Board authorized a share repurchase of up to $5.0 million on June 26, 2026; the company has repurchased 5,112,000 shares for about $1.11 million as of this date.
VieMed Healthcare furnished an August 2026 investor presentation under Regulation FD that reports second-quarter 2026 net revenue of $78.1 million, up 24% from a year earlier, and Adjusted EBITDA of $13.7 million. The deck restates full-year 2026 guidance and says the board authorized a new share repurchase program of up to 5% of shares outstanding.
2Q 2026 net revenue was $78.1 million, up 24% year over year; Adjusted EBITDA was $13.7 million.
2026 guidance: net revenue of $314 million to $320 million and Adjusted EBITDA of $64 million to $68 million.
New share repurchase program authorized for up to 5% of shares outstanding; 680,802 shares were bought in 1H 2026 for $6.5 million.
Net debt was effectively zero as of June 30, 2026, with $46 million of unfunded credit facility commitments.
GXO Logistics said its board approved Christina Carvalho as chief accounting officer, effective September 14, 2026, replacing interim chief accounting officer Laura Bracken on that date. The offer letter sets a $475,000 base salary, a 75% target bonus and a $1,000,000 sign-on equity award, which is a leadership change in the finance function rather than a change in company results.
Carvalho, 50, was Senior Vice President and Chief Accounting Officer of Amer Sports Inc. since April 2024.
Offer letter sets base salary at $475,000 and a target annual bonus of 75% of base salary.
Sign-on award of restricted stock units valued at $1,000,000, plus a 2027 annual equity grant target of no less than $400,000.
Laura Bracken ceases to serve as interim chief accounting officer effective September 14, 2026.
American Battery Technology reported preliminary, unaudited results for the quarter ended June 30, 2026, with revenue up 5.1% to $8.2 million and gross profit up 86% to $1.3 million from the prior quarter. The company also warned that a federal directive taking effect August 27, 2026 could block most of its foreign black mass sales, which it says make up the majority of total revenue and could have a material adverse effect.
Q4 FY26 revenue of $8.2 million, up 5.1% from $7.8 million in Q3 FY26
Gross profit of $1.3 million, up 86% from $0.7 million in Q3 FY26; cost of goods sold fell 2.8% to $6.9 million
Department of Commerce directive requires U.S. black mass sellers to allocate 100% of sales to U.S. persons, effective August 27, 2026; public comment period open until November 4, 2026
Company has submitted an exception request to BIS; there is no assurance it will be granted
Icahn Enterprises L.P. completed the previously announced sale of The Pep Boys-Manny, Moe & Jack Holding Corp. to a subsidiary of Mavis for approximately $700 million in cash, subject to customary purchase price adjustments. IEP retains the owned real estate transferred from Pep Boys, along with its AAMCO Transmissions and Precision Tune Auto Care businesses. The filing does not disclose the financial results or gain from the sale.
Buyer: Mavis Tire Supply, LLC, a subsidiary of Mavis Tire Express Services Corp.
Sale price: approximately $700 million in cash, subject to customary purchase price adjustments.
Seller: Icahn Automotive Group LLC, a wholly-owned IEP subsidiary; closed August 20, 2026.
Retained by IEP: owned real estate, AAMCO Transmissions and Precision Tune Auto Care businesses.
RF Acquisition Corp II shareholders voted on August 19, 2026, at an extraordinary general meeting and approved the Business Combination Proposal, which covers the merger with NYB Holdings Limited and the amalgamation with Nanyang Biologics Pte. Ltd. Holders also submitted preliminary requests to redeem 3,956,323 shares for cash from the trust account, and the company says the closing may not occur and the final redemption figures cannot be determined until closing.
Business Combination Proposal: 6,765,584 votes for, 440,604 against, 0 abstentions, out of 7,206,188 shares present (86.36% of 8,343,765 shares entitled to vote)
Preliminary redemption requests for 3,956,323 RFAC ordinary shares, subject to withdrawal or reversal before closing
Closing remains subject to closing conditions and may not occur; final redemption amounts will be disclosed after closing
Other proposals, including the merger, Nasdaq issuance, incentive plan and adjournment, received the same vote counts
Personalis received a new task order under its U.S. Department of Veterans Affairs contract for the Million Veteran Program, valued at up to $18.3 million and effective September 30, 2026. Cumulative task order value under the VA MVP contracts rose to approximately $243.3 million, though the order's value depends on receipt of samples and services performed.
New task order valued at up to $18.3 million, effective September 30, 2026
Task order is subject to receipt of VA MVP samples and performance of services by Personalis
Cumulative value of VA MVP task orders increased to approximately $243.3 million
Cantor Equity Partners I, Inc. (CEPO) and BSTR agreed on August 20, 2026 to terminate their business combination agreement in its entirety, with the parties releasing each other from related claims. Under the Termination and Release Agreement, the seller agreed to pay CEPO an aggregate of $15 million in cash, and CEPO's board will not call a shareholder meeting to approve the deal; CEPO intends to search for another target business.
Seller agreed to pay CEPO $15 million total: $10 million on September 19, 2026 and $5 million on December 1, 2026.
Business Combination Agreement, dated July 16, 2025 and amended March 25, 2026, is of no further force and effect.
Pubco and Newco intend to withdraw the Form S-4 filed May 14, 2026.
Cantor Fitzgerald & Co. engagement letters with CEPO and Pubco were terminated; the Subscription Agreements for private placements also terminated.
Thunder Bridge Capital Partners V, Ltd., a blank check company, completed its initial public offering on August 14, 2026, selling 30,015,000 units at $10.00 each, including the full exercise of the underwriter's over-allotment option, for gross proceeds of $300,150,000. The full amount was placed in a U.S. trust account, and the company has 24 months from closing to complete a business combination, with no target selected as of the filing.
IPO closed August 14, 2026: 26,100,000 units plus 3,915,000 over-allotment units, totaling 30,015,000 units at $10.00 each
Private placement of 747,000 units to the sponsor and Cantor for gross proceeds of approximately $7,470,000
$300,150,000 placed in trust account with Continental Stock Transfer & Trust Company as trustee
Company has not selected a business combination target and has until 24 months after the IPO closing to complete one
On August 20, 2026, James Hardie agreed to sell its European fiber gypsum and cement-bonded products business, including Fermacell, to a subsidiary of Holcim for €840 million, about $980 million. The company expects about $600 million of the proceeds to repay debt and has also authorized a $250 million share repurchase program. The sale is expected to close in the first half of 2027, and the company plans to wind down its European fiber cement operations, which are not included in the sale.
Buyer is Holcim Westbeteiligungs GmbH, a subsidiary of Holcim Ltd., with Holcim Ltd. as guarantor; price is €840 million, subject to net debt and working capital adjustments
About $600 million of proceeds is expected to repay debt, supporting a target of net leverage below 2.0x by September 30, 2027
Board authorized a share repurchase program of up to $250 million; the company is not obligated to buy any shares
Closing expected in the first half of calendar 2027, subject to antitrust approvals and employee consultations; the Purchaser may owe the Sellers a €15 million termination fee in certain circumstances
Devon Energy announced several executive leadership changes effective August 20, 2026, including new Executive Vice Presidents for Exploration & Production and a new Chief Technology Officer. Two former EVPs, John Raines and Michael DeShazer, are leaving the company as of September 1, 2026. The filing does not describe the reasons for the changes or any financial effect, so its direct impact on shareholders is unclear.
Tom Hellman named EVP, Exploration & Production, covering Anadarko, Eagle Ford, Marcellus and Rockies; previously SVP, New Ventures
Robert (Trey) Lowe III named EVP, Exploration & Production, covering Permian; previously EVP and Chief Technology Officer
Kevin Smith named EVP and Chief Technology Officer; previously SVP, Subsurface
John Raines and Michael DeShazer leaving the company as of September 1, 2026
Abbott agreed to resolve the Gill lawsuit and necrotizing enterocolitis claims for about 2,000 other infants for an aggregate of approximately $670 million, instead of continuing its appeal or paying about $600 million on the Gill judgment plus interest. The company states the agreements are a compromise and not an admission of liability, but the payment is a sizable cost, and roughly 1,700 lawsuits involving about 12,700 infants remain pending.
Gill case: July 2024 Missouri jury verdict of $495 million, affirmed by the Missouri Court of Appeals in May 2026.
Settlement: aggregate amount of approximately $670 million covering the Gill case and claims for about 2,000 additional infants.
Alternative cited: paying approximately $600 million, the Gill judgment plus accrued interest to date.
Remaining litigation: roughly 1,700 lawsuits involving claims for about 12,700 individual infants.
Corteva's subsidiary EIDP entered a supplemental indenture on August 20, 2026, that removes most restrictive covenants and events of default from its notes, with the changes taking effect only when Vylor's exchange offers settle alongside the separation. The filing says the amendments were approved by the required majority of noteholders as of August 19, 2026, and would not take effect if the separation is not completed.
On August 20, 2026, EIDP entered a fourth supplemental indenture with U.S. Bank Trust Company as trustee.
The proposed amendments would eliminate substantially all restrictive covenants and events of default, other than payment and bankruptcy-related defaults.
Vylor received the required consents from noteholders as of August 19, 2026; the amendments become operative only at settlement of the exchange offers, expected alongside the separation.
On August 14, 2026, subsidiaries EV Gen Set 1, LLC and EV Gen Set I HoldCo, LLC entered into a senior secured term loan facility of approximately $137.5 million with CSC Delaware Trust Company as agent and a group of lenders. Loans are drawn in installments to pay for power generation equipment and installation services under an Equipment Supply Agreement, and the facility matures on January 2, 2028. For shareholders, this adds $137.5 million of secured debt, with interest rates set to rise after December 31, 2026.
Approximately $137.5 million senior secured term loan dated August 14, 2026, with CSC Delaware Trust Company as administrative and collateral agent
Interest of 6.75% on SOFR loans and 5.75% on ABR loans through December 31, 2026, rising to 7.50% and 6.50% thereafter
Facility matures January 2, 2028; borrower may prepay on three Business Days' notice, subject to accrued interest, breakage costs and a repayment premium
Loans are secured by a first priority interest in substantially all assets of the borrower and Holdings and guaranteed by Holdings; borrower must keep a debt service reserve covering three months of debt service
Royal Caribbean completed a $1.25 billion offering of 5.550% senior notes maturing January 20, 2034, on August 20, 2026. The company expects net proceeds of about $1.24 billion, which it plans to use mainly to repay part of its floating rate term loan borrowings and any remaining amount to repay or refinance other debt.
Principal amount of $1.25 billion of 5.550% senior notes due January 20, 2034
Net proceeds of about $1.24 billion, to repay part of floating rate term loan borrowings and other existing debt
Interest accrues from August 20, 2026 and is paid semi-annually on January 20 and July 20, starting January 20, 2027
Beacon Financial Corporation completed the sale of $175 million of 6.25% fixed-to-floating rate subordinated notes due September 1, 2036, on August 20, 2026. The company estimates net proceeds of about $171.8 million, which it plans to use with cash on hand, if needed, to redeem its $75 million 6.0% notes due 2029 and for general corporate purposes, so the transaction changes the company's debt mix rather than its operating results.
$175 million of subordinated notes issued August 20, 2026, maturing September 1, 2036
Fixed 6.25% interest until September 1, 2031, then resets quarterly to Three-Month Term SOFR plus 2.15%
Estimated net proceeds of approximately $171.8 million
$75 million 6.0% notes due 2029 to be redeemed in full on September 15, 2026, at 100% of principal plus accrued interest
New Jersey Natural Gas, a wholly-owned subsidiary of New Jersey Resources, agreed on August 20, 2026 to sell $150 million of senior notes in three series to institutional investors. The Series A and Series B notes, totaling $100 million, closed the same day, and the $50 million Series C notes are expected to close on October 22, 2026. The notes are secured by the subsidiary's first mortgage bonds, and the parent company is not directly or contingently obligated, so the debt sits at the utility subsidiary level.
$50 million 5.43% Series A notes due August 20, 2036, closed August 20, 2026
$50 million 6.04% Series B notes due August 20, 2056, closed August 20, 2026
$50 million 5.43% Series C notes due October 22, 2036, expected to close October 22, 2026
Proceeds are for general corporate purposes, including refinancing short-term debt and funding capital expenditures
On August 20, 2026, OneMain Finance Corporation, a subsidiary of OneMain Holdings, issued $600 million of 7.125% senior notes maturing March 15, 2034, under an underwritten public offering. The notes add $600 million of unsecured debt at the subsidiary level, guaranteed by OneMain Holdings, which shareholders may track in the company's overall debt load.
Principal amount: $600 million, issued August 20, 2026 by OneMain Finance Corporation
Interest of 7.125% per year, paid semiannually on March 15 and September 15, starting March 15, 2027
Maturity date March 15, 2034; guaranteed on an unsecured basis by OneMain Holdings, Inc.
Redeemable at make-whole price before August 15, 2029, and at 103.5625% in 2029, 101.7813% in 2030, and 100% from 2031
On August 17, 2026, NexPoint Real Estate Finance amended its senior secured loan facility with Mizuho Capital Markets, raising the borrowing limit from $375.0 million to $450.0 million and adding assets as collateral. The company also amended a related total return swap, under which it transferred about $144.3 million of cash collateral to Mizuho and will owe an upfront fee, which means more secured debt and cash tied up in the arrangement for shareholders.
Facility borrowing limit increased from $375.0 million to $450.0 million under the August 17, 2026 amendment
$412.2 million was outstanding under the facility as of August 17, 2026
Variable rate of daily compounded SOFR, with a 2.0% floor, plus 4.0% per annum; matures May 1, 2029, with two optional six-month extensions
About $144.3 million of cash collateral transferred to Mizuho; upfront fee owed; make-whole payments may apply to certain early swap terminations
Suja Life entered an Amended and Restated Credit Agreement on August 20, 2026, with JPMorgan Chase Bank, N.A. as administrative agent, replacing its August 23, 2021 credit agreement. The main change is a lower interest rate, and the company expects its 2026 total interest expense to improve to $18.0 million; the CFO said the deal adds no new debt.
Interest rate is Term SOFR plus 1.75%, 2.00%, or 2.25% per annum, based on the consolidated net leverage ratio
Company expects 2026 total interest expense to improve to $18.0 million
CFO Jeff Pedersen said the transaction does not add debt and reduces the cost of carrying existing debt
Agreement dated August 20, 2026, between indirect subsidiaries and JPMorgan Chase Bank, N.A.
Genworth Financial said Thomas J. McInerney will return from a leave of absence and resume the role of President and Chief Executive Officer effective September 2, 2026. Jerome T. Upton, who has been interim President and CEO, will stop serving in that capacity on the same date and remain Executive Vice President and Chief Financial Officer.
Thomas J. McInerney resumes the President and CEO role effective September 2, 2026
He will resume day-to-day operational responsibilities and serve as principal executive officer
Jerome T. Upton ends his interim CEO role on September 2, 2026 and remains Executive Vice President and CFO
ClearSign Technologies reported second quarter 2026 revenue of about $560,000, up from about $133,000 a year earlier, and a smaller net loss, which fell by $373,000 on lower general and administrative expenses. The company also said it sold 500,000 shares at $3.54 on July 21, 2026, adding about $1.7 million in net proceeds, and that six M1 Series burners were ordered from two midstream customers in West Texas.
Q2 2026 revenue was about $560,000 versus about $133,000 in Q2 2025; gross margin was about 41%, roughly flat year over year.
Net loss decreased by $373,000 year over year, mainly from a $368,000 decrease in general and administrative expenses.
Cash and cash equivalents were about $9.9 million at June 30, 2026; pro forma for the July 21 share sale, about $11.6 million.
Larry Saddler, a retired ExxonMobil executive, was appointed to the Board of Directors.
Edesa Biotech, Inc. priced an underwritten public offering of 3,870,500 common shares and pre-funded warrants for up to 675,000 common shares, each sold with a common share warrant, with gross proceeds expected to be approximately $25.0 million. The company expects net proceeds of approximately $23.1 million, to be used for general corporate purposes, and expects the offering to close on or about August 21, 2026, which adds new shares and warrants that can dilute existing shareholders.
Combined offering price of $5.50 per common share with a warrant, and $5.4999 per pre-funded warrant with a warrant.
Expected net proceeds of approximately $23.1 million; closing expected on or about August 21, 2026.
Warrants have a $7.50 exercise price and expire on the earlier of the 18-month anniversary of issuance or 30 days after public announcement of Phase 2 vitiligo topline data for EB06.
Underwriters hold a 30-day option to buy up to 681,825 additional shares; executive officers and directors agreed to a 90-day lock-up, subject to exceptions.
Dynatrace subsidiary Dynatrace LLC issued $1.4375 billion of 0.00% exchangeable senior notes due September 1, 2031, on August 20, 2026, including the full $187.5 million option. The company also used about $134.7 million of net proceeds to repurchase about 2.83 million shares of its common stock, and terminated its senior secured revolving credit facility. The notes are exchangeable into cash, shares or both, which could dilute shareholders if exchanged into stock, though hedge and warrant transactions are intended to offset part of that dilution.
Notes issued August 20, 2026: $1.4375 billion principal, 0.00% interest, maturing September 1, 2031
Net proceeds of about $1.411 billion; about $167.8 million used for the note hedge cost, net of warrant proceeds
About $134.7 million used to repurchase about 2.83 million shares at $47.61, the August 17, 2026 closing price
Initial exchange price of about $64.27 per share; the revolving credit facility was terminated with only cash-collateralized letters of credit outstanding
Ross Stores reported second-quarter fiscal 2026 sales of $6.3 billion, up 13%, with comparable store sales up 10%. Diluted earnings per share were $2.66 versus $1.56 a year earlier, including an approximate $0.60 benefit from $253 million in IEEPA tariff refunds, and the company raised its third- and fourth-quarter and full-year 2026 earnings per share projections.
Q2 sales $6.3 billion, up 13% from $5.5 billion; comparable store sales up 10%
Diluted EPS $2.66 vs. $1.56 a year ago, including about $0.60 from tariff refunds; prior guidance was $1.85 to $1.93
Fiscal 2026 EPS projection raised to $8.61 to $8.77; Q3 comparable sales guidance 6% to 7%, Q4 4% to 5%
2026 new store plan raised to 115 locations; company remains on track to repurchase $1.275 billion of stock in fiscal 2026
Flowers Foods reported second-quarter results for the 12 weeks ended July 18, 2026, with net sales down 4.0% to $1.193 billion and net income down 30.3% to $40.7 million, or $0.19 per diluted share. The company lowered its full-year 2026 outlook for net sales, adjusted EBITDA and adjusted diluted EPS, citing a more cautious view for the rest of the year. Shareholders face lower expected earnings for 2026 than previously guided.
Net sales fell 4.0% to $1.193 billion, with volume down 5.8% and pricing/mix up 1.8%.
Adjusted EBITDA fell 19.2% to $111.3 million, and adjusted diluted EPS fell $0.09 to $0.21.
Full-year 2026 adjusted diluted EPS guidance was cut to $0.75 to $0.85 from $0.80 to $0.90; net sales guidance was cut to $5.070 billion to $5.142 billion from $5.163 billion to $5.267 billion.
Management will host a live question-and-answer webcast at 8:30 a.m. Eastern Time on August 21, 2026.
Evolution Petroleum agreed on August 18, 2026 to sell 3,700,000 common shares at $3.25 per share, and the underwriters exercised their option in full on August 19 for 555,000 more shares. The company received net proceeds of approximately $12.4 million, and the offering closed on August 20, 2026. The company plans to use the proceeds to help fund a previously announced Permian Basin mineral and royalty acquisition, but the offering is not conditioned on that deal closing.
3,700,000 shares priced at $3.25 per share on August 18, 2026; Roth Capital Partners acted as representative of the underwriters.
Underwriters exercised the 30-day option in full on August 19, 2026, for 555,000 additional shares.
Net proceeds of approximately $12.4 million; the offering closed on August 20, 2026.
Proceeds are intended for part of the Permian Basin acquisition price, credit facility borrowings, cash on hand and general corporate purposes; the company cannot assure the acquisition will be completed.
On August 19, 2026, Ensign Group entered into a Fourth Amended and Restated Credit Agreement with Truist Bank as administrative agent, increasing the revolving facility by $200.0 million to up to $800.0 million and extending maturity to August 19, 2031. The company says the facility provides liquidity for acquisitions, capital investments and general purposes, while the borrowings are secured by certain assets and guaranteed by certain domestic subsidiaries.
Aggregate revolving capacity rises by $200.0 million to up to $800.0 million.
Maturity extended from the prior agreement to August 19, 2031.
Interest is base rate plus 0.25% to 1.00%, or Term SOFR plus 1.25% to 2.00%, based on the leverage ratio; unused commitment fee is 0.175% to 0.30%.
Borrowers' obligations are joint and several, guaranteed by certain domestic subsidiaries and secured by liens on certain assets.
Lifetime Brands entered into a $60.0 million second lien term loan and amended its $200.0 million ABL revolving credit facility, both maturing August 17, 2031. The new term loan repaid its existing term loan B, and the filing says the refinancing extends the company's debt maturities, though the term loan carries margins of 6.75% to 8.25%.
Term Loan: $60.0 million, funded in full on August 17, 2026, maturing August 17, 2031, with quarterly principal payments of 1.25% starting October 1, 2027
Term loan margin: 6.75% to 7.25% over Term SOFR, or 7.75% to 8.25% over base rate, depending on ABL availability
ABL facility: $200.0 million revolving commitments, amended and extended to August 17, 2031, with margins fixed at 1.75% for term benchmark loans through the quarter ending on or about September 30, 2026
Term loan covenant requires Adjusted EBITDA of at least $30.0 million, measured monthly on a trailing twelve-month basis
On August 14, 2026, Werewolf Therapeutics agreed to sell its pre-clinical INDUCER and INDUKINE platform technology to EMD Serono, with EMD paying $28.0 million upfront and an additional $5.0 million upon completion of the technology transfer. The company keeps its WTX-124 and WTX-330 clinical programs and received an exclusive license to certain patents needed to develop them, but it agreed to a 24-month non-competition covenant on certain related compounds.
Upfront consideration of $28.0 million, plus an additional $5.0 million upon completion of the technology transfer
Sold INDUCER and INDUKINE pre-clinical platforms and related compounds, excluding the WTX-124 and WTX-330 clinical programs
Company retains rights to continue developing WTX-124 and WTX-330
Non-competition covenant for 24 months after closing, with customary exceptions for change of control transactions
Veeva Systems said Dan Rizzo will become EVP, Sales, Consulting, and Services effective October 2, 2026, succeeding Thomas D. Schwenger, who is resigning from his role as President and Chief Customer Officer. Schwenger, who has been with Veeva since September 2019, is leaving to become CEO of a long-standing Veeva partner, a change that moves a senior sales and customer leadership role to a new executive.
Dan Rizzo appointed EVP, Sales, Consulting, and Services, effective October 2, 2026
Thomas D. Schwenger resigned on August 18, 2026; resignation effective October 2, 2026
Schwenger had been with Veeva since September 2019, most recently as President and Chief Customer Officer
The filing does not state Rizzo's prior role or compensation terms
Merit Medical said it eliminated its Chief Operating Officer position in an August 14, 2026 reorganization and named Sheri Lewis Executive Vice President of Global Operations, effective August 31, 2026. Neil W. Peterson, the former COO, became Senior Advisor and has given notice of resignation for good reason effective March 5, 2027. The filing describes a leadership change in the operations function without any reported financial results.
Sheri Lewis appointed EVP of Global Operations effective August 31, 2026, with a $600,000 base salary and $400,000 signing bonus
Lewis's target annual bonus is 60% of base salary, with a maximum of 200%
Neil W. Peterson's COO title was changed to Senior Advisor; his resignation takes effect March 5, 2027
Lewis's agreement provides a lump sum of two times salary plus bonus average if terminated without cause or for good reason after a change of control
OSI Systems reported fiscal fourth-quarter revenue of $484.1 million, down 4% from a year earlier, while GAAP diluted EPS rose 8% to $3.27. Management attributed the revenue decline to Middle East conflicts that shifted the timing of some deliveries, and said the delays do not reflect order cancellations. The company also introduced fiscal 2027 guidance and its board added 1 million shares to the buyback authorization.
Q4 revenue $484.1 million, down 4%; GAAP diluted EPS $3.27, up 8%; non-GAAP diluted EPS $3.78, up 17%
Fiscal 2026 revenue $1.79 billion, up 4%; GAAP diluted EPS $8.95, up 3%; backlog about $1.9 billion as of June 30, 2026
Fiscal 2027 guidance: revenue $1.875 billion to $1.930 billion; non-GAAP diluted EPS $11.13 to $11.49
Board approved 1 million additional shares for repurchase, bringing total remaining authorization to 1,078,731 shares
Boston Beer's Treasurer and Chief Financial Officer, Diego Reynoso, is stepping down, with his departure not tied to any disagreement with the company, and he will remain through September 30, 2026. Chief Accounting Officer Matthew D. Murphy will serve as interim Treasurer and CFO starting September 15, 2026, while the board runs a search for a permanent successor.
Diego Reynoso informed the company on August 17, 2026 that he is stepping down as Treasurer and CFO; he stays through September 30, 2026.
Matthew D. Murphy, age 57, becomes interim Treasurer and CFO effective September 15, 2026; he previously served as interim CFO from March 2023 to September 2023.
Murphy's base salary is unchanged at $419,359.41, with a target bonus of 50% of base salary and a target annual equity value of $250,000.
Murphy will receive a cash bonus of up to $700,000 in four installments, the first payable December 31, 2026 and the last March 1, 2028, subject to continued employment.
Popular, Inc. has set compensation for its new President and Chief Executive Officer, Jorge J. García, and its new Executive Vice President and Chief Financial Officer, Lidio V. Soriano, with both appointments effective September 1, 2026. The filing shows a $1,150,000 base salary for García and a $670,000 base salary for Soriano, plus a one-time $977,833 restricted stock award to García, which is a fixed cost for shareholders to note in the company's executive pay.
Jorge J. García: base salary $1,150,000; target short-term cash incentive 135% of salary; target long-term equity incentive 325% of salary
García received a one-time Promotion Award of $977,833 in restricted stock, granted August 19, 2026
Lidio V. Soriano: base salary $670,000; target short-term cash incentive 80% of salary; target long-term equity incentive 120% of salary
Hovnanian reported fiscal third-quarter 2026 revenue of $705.7 million, down from $800.6 million a year earlier, and a net loss available to common stockholders of $4.5 million, or $0.70 per diluted share, compared with net income of $13.9 million, or $1.99 per share. Management said adjusted pretax results came in below its guided range, and it issued fourth-quarter guidance for revenue of $800 million to $900 million.
Q3 total revenues were $705.7 million versus $800.6 million in the prior-year quarter; the company said this was within its guidance range.
Net loss available to common stockholders was $4.5 million, or $0.70 per diluted share, versus net income of $13.9 million, or $1.99 per share, a year earlier.
Adjusted loss before income taxes was $2.3 million, compared with adjusted income of $39.8 million in the third quarter of fiscal 2025; adjusted EBITDA was $31.9 million, within guidance.
Fourth-quarter fiscal 2026 guidance: total revenues of $800 million to $900 million, adjusted income before income taxes of $15 million to $30 million, and adjusted EBITDA of $50 million to $65 million.
Exyn Technologies reported second-quarter 2026 revenue of $950 thousand, down from $1.4 million a year earlier, and a net loss of $6.9 million, up from $2.9 million, although gross margin rose to 46.9%. The same day, the company said Chief Operating Officer Ben Williams would serve as interim chief executive and independent director Gregory McNeal as chairman, following the resignation of Brandon Torres Declet as CEO and chairman, which adds leadership change to weaker results for shareholders.
Revenue was $950 thousand in Q2 2026 versus $1.4 million in Q2 2025; the company cited the timing of customer deployments.
Net loss was $6.9 million, or $1.55 per share, versus $2.9 million, or $2.22 per share, a year earlier.
Gross margin rose 630 basis points to 46.9%; cash and cash equivalents were about $7.8 million as of June 30, 2026.
Ben Williams was appointed interim CEO and Gregory McNeal chairman, both effective August 19, 2026.
Nasdaq notified BullFrog AI Holdings that it is eligible for a second 180-day period, until February 8, 2027, to regain the $1.00 minimum closing bid price, which the company has not yet met. The company plans to effect a reverse stock split before the period ends if the price is not cured organically, and failure to regain compliance would make its listed securities subject to delisting.
Nasdaq notice dated August 18, 2026; the first compliance period ended August 10, 2026.
Second Compliance Period runs until February 8, 2027; compliance requires at least $1.00 closing bid for a minimum of 10 consecutive business days.
Stockholders approved in October 2025 a reverse stock split ratio between 1-to-2 and 1-to-15, to be set by the Board.
The company states there is no assurance it will regain compliance during the period.
Skyward Specialty Insurance Group said its Chief Financial Officer, Mark Haushill, will retire effective March 31, 2027, and will serve as a Senior Advisor through December 31, 2027. Taryn McHarg, currently Chief Financial Officer of Apollo and Deputy Chief Financial Officer of the Company, will succeed him as CFO upon his retirement. The filing describes the retirement as not resulting from any disagreement with the Company, and it reports no financial results.
Mark Haushill, CFO, notified the Company on August 17, 2026 of his intention to retire effective March 31, 2027.
Haushill's Senior Advisor role runs March 31, 2027 through December 31, 2027 at an annualized base salary of $250,000, with no annual bonus or new equity awards.
Taryn McHarg, age 48, will become CFO and Principal Financial Officer and Principal Accounting Officer; her base salary is approximately $540,000 with a target bonus of 20% to 60%.
BTCS reported second-quarter 2026 results, with total revenue up 14% from the first quarter to $2.4 million and gross profit up 47% to $1.5 million at a 61% margin, driven by its Imperium DeFi business. The company still posted a net loss of $34.9 million, mainly from non-cash digital asset losses, though that was smaller than the $69.1 million loss in the first quarter and the company had net income of $3.9 million in the year-earlier quarter.
Total revenue was $2.4 million for Q2 2026, up 14% from $2.1 million in Q1 2026; DeFi revenue from Imperium rose 48% to $1.5 million.
Gross profit was $1.5 million (61% margin) versus $1.0 million (47% margin) in Q1 2026.
Net loss was $34.9 million for Q2 2026, compared with a net loss of $69.1 million in Q1 2026 and net income of $3.9 million in Q2 2025.
Total debt fell to $50.4 million as of June 30, 2026, from $74.8 million on March 31, 2026, and total assets were $89.3 million.
On August 19, 2026, ScanSource agreed to acquire MicroAge, a technology provider, for $220.5 million in cash at closing, with closing expected in September 2026 subject to antitrust waiting-period expiration and third-party consents. On August 20, the company reported fourth-quarter fiscal 2026 net sales of $953.1 million, up 17.3%, and GAAP diluted EPS of $1.24 versus $0.88, and issued fiscal 2027 guidance that excludes the pending MicroAge deal.
Purchase price is $220.5 million in cash at closing, with $3 million in escrow for purchase price adjustments and $6.8 million for indemnification claims.
Q4 fiscal 2026 (quarter ended June 30, 2026): net sales $953.1 million, up 17.3%; GAAP diluted EPS $1.24 versus $0.88 a year earlier.
Fiscal 2026 GAAP net income was $78.9 million, or $3.64 per diluted share, versus $3.00; cash was $88.4 million and total debt was $101.4 million at June 30, 2026.
Fiscal 2027 outlook (excluding MicroAge): net sales growth of 6% to 10%, adjusted EBITDA of $158 million to $165 million, and free cash flow of at least $85 million.
Binah Capital Group furnished an investor presentation under Regulation FD for use at the Sidoti Virtual Micro Cap Conference beginning August 19, 2026. The deck shows second-quarter 2026 revenue up 12.1% year over year, net income of $338 thousand compared with a net loss a year earlier, and first-half EBITDA up 79%.
Q2 2026 total revenue was $46.5 million, up from $41.5 million in Q2 2025.
Q2 2026 net income was $338 thousand, compared with a net loss of $654 thousand in Q2 2025.
Q2 2026 EBITDA was $1.0 million versus $0.1 million a year earlier; first-half EBITDA rose 79% to $4.3 million.
The presentation will be used at the Sidoti Virtual Micro Cap Conference beginning August 19, 2026.
LSI Industries reported fiscal fourth-quarter 2026 net sales of $234.6 million, up 51% year over year, helped by the Royston Group acquisition, with organic growth of 8%. GAAP net income fell 16% to $6.9 million ($0.18 per diluted share), though adjusted EPS rose to $0.38 from $0.34, and the company declared a $0.05 quarterly dividend.
Q4 net sales $234.6 million, up 51%; Royston contributed $66.9 million; organic sales up 8%
Q4 diluted EPS $0.18 as reported vs. $0.26 a year earlier; adjusted EPS $0.38 vs. $0.34
Fiscal 2026 net sales record $689.4 million, up 20%; GAAP net income $22.6 million vs. $24.4 million
Regular quarterly dividend of $0.05 per share payable September 8, 2026, to holders of record August 31, 2026
Jack in the Box appointed Taylor Montgomery, formerly Global Chief Brand Officer at Taco Bell, as President effective September 14, 2026, in a newly created role leading brand strategy. The company says he is expected to become CEO within the next twelve months and join the Board at that time, as part of its previously announced CEO succession plan. The filing contains no financial results for the period.
Appointment effective September 14, 2026; Mr. Montgomery is 39 and will lead brand strategy in the newly created President role.
Expected to assume the CEO role within the next twelve months; Mark King, Executive Chairman and Interim CEO, will remain Chairman after the transition.
Offer letter includes a $700,000 base salary, a target annual incentive of 75% of salary, a $1.5 million inducement RSU grant and a $220,000 sign-on bonus.
Performance Food Group said Matthew C. Flanigan will succeed Manuel A. Fernandez as Lead Independent Director after the 2026 Annual Meeting, and that Fernandez and three other directors will not stand for reelection. The Board will shrink from 14 to 10 directors, eight of them independent, and George L. Holm will move from Executive Chair to Non-Executive Chair effective January 1, 2027. The company said the departures were not the result of any disagreement with the company or the Board.
Board to decrease from 14 to 10 directors after the 2026 Annual Meeting, with eight independent
Matthew C. Flanigan, current Audit and Finance Committee chair, to succeed Manuel A. Fernandez, who has served as Lead Independent Director since 2019
Fernandez, William F. Dawson, Jr., Laura Flanagan and Scott D. Ferguson will not stand for reelection
George L. Holm becomes Non-Executive Chair effective January 1, 2027, having been Executive Chair
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.